Loading...
01/10 12:58
Loading...
Crinetics Pharmaceuticals Inc (CRNX) is set to release its earnings performance on 11/06 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 394.00K and an earnings per share (EPS) of -1.27 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call highlights strong product development and market strategy, especially with the PALSONIFY launch and its appeal to both patients and prescribers. The Q&A section indicates effective execution and positive reception, despite minor uncertainties in payer approval timing. Financial guidance shows controlled cash usage, and the company is well-capitalized. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
The earnings call reveals a mix of positive and cautious elements. While the CRENESSITY launch and positive payer feedback are promising, management's reluctance to comment on consensus numbers and pricing, along with limited updates on liver toxicity and distribution, indicate uncertainty. The market cap suggests moderate sensitivity to news, warranting a neutral prediction.
The earnings call presents a mixed picture: strong year-over-year revenue growth and a decrease in net loss are positive, but lack of current revenue and a net loss remain concerns. The Q&A section reveals uncertainty in regulatory timelines and data disclosures, which can dampen investor confidence. Although there's optimism about paltusotine's market potential and strategic preparations, the absence of immediate revenue and regulatory risks balance out the positives. Given the mid-cap status of Crinetics, the stock is likely to experience a neutral movement in the short term.
The earnings call reveals significant financial challenges, including a sharp revenue decline and increased net losses. Despite having substantial cash reserves, the anticipated high cash burn for 2025 raises concerns. The Q&A section highlights management's lack of clarity on timelines and specifics, which may further unsettle investors. Given these factors and the mid-sized market cap, a negative stock price reaction is likely over the next two weeks.
Crinetics Pharmaceuticals Inc (CRNX) is scheduled to release its FY2025Q3 earnings report onNov 6, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 394.00K in revenue and an EPS of -1.27 for Crinetics Pharmaceuticals Inc's FY2025Q3.
Intellectia's exclusive AI algorithms forecast a forCrinetics Pharmaceuticals Inc's FY2025Q3 earnings, with a prediction date of Nov 6, 2025. Crinetics Pharmaceuticals Inc
Leverage Intellectia's AI forecast to position trades ahead of theNov 6, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
